EGR3 and acute myeloid leukemia: P21 and EGr3 are intrinsic factors involved in blocking the differentiation of normal HSCs in acute myeloid leukemia due to the binding of SMAD3, an active transducer of transforming growth factor β1 (TGFβ1), to Egr3 [70].